StockData
Sanofi logo

Sanofi (SNY) stock

SNYNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SNYNF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 17, 2026Score 6/30
$47.12−0.41 (-0.86%)

Close on Nov 18, 2026Market cap $114.92BP/E 13.4Yield –

Sanofi operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was €10.75B, up 18.4% from the year before. Over ten years it grew 2.6% a year on average. The highest annual figure on record is €10.75B in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025€10.75B+18.4%
FY2024Dec 31, 2024€9.08B-11.5%
FY2023Dec 31, 2023€10.26B-2.5%
FY2022Dec 31, 2022€10.53B+0.0%
FY2021Dec 31, 2021€10.52B+41.8%
FY2020Dec 31, 2020€7.42B-3.8%
FY2019Dec 31, 2019€7.72B+39.1%
FY2018Dec 31, 2018€5.55B-24.8%
FY2017Dec 31, 2017€7.38B-5.9%
FY2016Dec 31, 2016€7.84B-5.5%
FY2015Dec 31, 2015€8.29B–

More Sanofi figures

See a number that looks wrong?